Screening of precancerous gastric lesions by serum pepsinogen, gastrin-17, anti-helicobacter pylori and anti-caga antibodies in dyspeptic patients over 50 years old in Guilan Province, North of Iran

15Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

Background: The aim of this study was to investigate the value of serum gastric markers to differentiate between patients with precancerous lesions and nonatrophic chronic gastritis. Materials and Methods: Serum samples of 128 patients with dyspepsia who were candidates for endoscopic examination were tested for pepsinogen (PG I and PG II), PG I/II ratio, gastrin 17(G-17), anti-Helicobacter pylori (anti-H pylori) and anti-CagA antibodies. Two sample t-tests, chi-square tests and Pearson's correlation analyses were used for analysis using SPSS (version 20). Results: PGI, PG I/II ratio values were decreased significantly in the precancerous lesion group (0.05, 0.001 respectively). The frequency of H pylori infection was signifificantly (p=0.03) different between the two groups ofthe study. Conclusions: We suggest PGI and the PG I/II ratio as valuable markers for screening of premalignant gastric lesions.

Cite

CITATION STYLE

APA

Mansour-Ghanaei, F., Joukar, F., Rajpout, Y., & Hasandokht, T. (2014). Screening of precancerous gastric lesions by serum pepsinogen, gastrin-17, anti-helicobacter pylori and anti-caga antibodies in dyspeptic patients over 50 years old in Guilan Province, North of Iran. Asian Pacific Journal of Cancer Prevention, 15(18), 7635–7638. https://doi.org/10.7314/APJCP.2014.15.18.7635

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free